Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 109 to 116 of 116 entries
Sorted by: Best Match Show Resources per page
The demographic and serological characteristics of COVID-19 convalescent plasma donors: Identification of basic criteria for optimal donor selection.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Fazeli A, Sharifi S, Mohammadi S, Bahraini M, Arabkhazaeli A, Jelveh N, Eshghi P.
PMID: 34774440
Transfus Apher Sci. 2021 Oct 29;103302. doi: 10.1016/j.transci.2021.103302. Epub 2021 Oct 29.

BACKGROUND AND OBJECTIVES: Convalescent plasma has attracted significant attention as a therapeutic option against infectious agents for more than a century. In March 2020, the use of Convalescent COVID-19 plasma (CCP) as a new research drug for COVID-19 treatment...

Cite
Fazeli A, Sharifi S, Mohammadi S, et al. The demographic and serological characteristics of COVID-19 convalescent plasma donors: Identification of basic criteria for optimal donor selection. Transfus Apher Sci. 2021;103302doi: 10.1016/j.transci.2021.103302.
Fazeli, A., Sharifi, S., Mohammadi, S., Bahraini, M., Arabkhazaeli, A., Jelveh, N., & Eshghi, P. (2021). The demographic and serological characteristics of COVID-19 convalescent plasma donors: Identification of basic criteria for optimal donor selection. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 103302. https://doi.org/10.1016/j.transci.2021.103302
Fazeli, Alieh, et al. "The demographic and serological characteristics of COVID-19 convalescent plasma donors: Identification of basic criteria for optimal donor selection." Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis vol. (2021): 103302. doi: https://doi.org/10.1016/j.transci.2021.103302
Fazeli A, Sharifi S, Mohammadi S, Bahraini M, Arabkhazaeli A, Jelveh N, Eshghi P. The demographic and serological characteristics of COVID-19 convalescent plasma donors: Identification of basic criteria for optimal donor selection. Transfus Apher Sci. 2021 Oct 29;103302. doi: 10.1016/j.transci.2021.103302. Epub 2021 Oct 29. PMID: 34774440; PMCID: PMC8554042.
Copy Download .nbib Format: NLM
Extracellular vesicle research in reproductive science- Paving the way for clinical achievements.

Biology of reproduction

Aleksejeva E, Zarovni N, Dissanayake K, Godakumara K, Vigano P, Fazeli A, Jaakma Ü, Salumets A.
PMID: 34982163
Biol Reprod. 2022 Jan 04; doi: 10.1093/biolre/ioab245. Epub 2022 Jan 04.

Mammalian conception involves a multitude of reciprocal interactions via a molecular dialogue between mother and conceptus. Extracellular vesicles (EVs) are secreted membrane-encapsulated particles that mediate cell-to-cell communication in various contexts. EVs, which are present in seminal, follicular, oviductal, and...

Cite
Aleksejeva E, Zarovni N, Dissanayake K, et al. Extracellular vesicle research in reproductive science- Paving the way for clinical achievements. Biol Reprod. 2022;doi: 10.1093/biolre/ioab245.
Aleksejeva, E., Zarovni, N., Dissanayake, K., Godakumara, K., Vigano, P., Fazeli, A., Jaakma, �. �., & Salumets, A. (2022). Extracellular vesicle research in reproductive science- Paving the way for clinical achievements. Biology of reproduction, . https://doi.org/10.1093/biolre/ioab245
Aleksejeva, Elina, et al. "Extracellular vesicle research in reproductive science- Paving the way for clinical achievements." Biology of reproduction vol. (2022). doi: https://doi.org/10.1093/biolre/ioab245
Aleksejeva E, Zarovni N, Dissanayake K, Godakumara K, Vigano P, Fazeli A, Jaakma Ü, Salumets A. Extracellular vesicle research in reproductive science- Paving the way for clinical achievements. Biol Reprod. 2022 Jan 04; doi: 10.1093/biolre/ioab245. Epub 2022 Jan 04. PMID: 34982163.
Copy Download .nbib Format: NLM
Improvement of thermostability of cholesterol oxidase from streptomyces Sp. SA-COO by random mutagenesis.

Protein expression and purification

Fazaeli A, Fana SE, Golestani A, Aminian M.
PMID: 34863881
Protein Expr Purif. 2021 Dec 01;191:106028. doi: 10.1016/j.pep.2021.106028. Epub 2021 Dec 01.

To enhance the thermal stability of Streptomyces Sp. SA-COO cholesterol oxidase, random mutagenesis was used. A random mutant library was generated using two types of error-prone PCR (single step and serial dilution) and two mutants (ChOA-M1 and ChOA-M2) with...

Cite
Fazaeli A, Fana SE, Golestani A, et al. Improvement of thermostability of cholesterol oxidase from streptomyces Sp. SA-COO by random mutagenesis. Protein Expr Purif. 2021;191:106028doi: 10.1016/j.pep.2021.106028.
Fazaeli, A., Fana, S. E., Golestani, A., & Aminian, M. (2021). Improvement of thermostability of cholesterol oxidase from streptomyces Sp. SA-COO by random mutagenesis. Protein expression and purification, 191106028. https://doi.org/10.1016/j.pep.2021.106028
Fazaeli, Aliakbar, et al. "Improvement of thermostability of cholesterol oxidase from streptomyces Sp. SA-COO by random mutagenesis." Protein expression and purification vol. 191 (2021): 106028. doi: https://doi.org/10.1016/j.pep.2021.106028
Fazaeli A, Fana SE, Golestani A, Aminian M. Improvement of thermostability of cholesterol oxidase from streptomyces Sp. SA-COO by random mutagenesis. Protein Expr Purif. 2021 Dec 01;191:106028. doi: 10.1016/j.pep.2021.106028. Epub 2021 Dec 01. PMID: 34863881.
Copy Download .nbib Format: NLM
SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor Microenvironment.

Cancers

Zhu Y, Ferri-Borgogno S, Sheng J, Yeung TL, Burks JK, Cappello P, Jazaeri AA, Kim JH, Han GH, Birrer MJ, Mok SC, Wong STC.
PMID: 33917869
Cancers (Basel). 2021 Apr 08;13(8). doi: 10.3390/cancers13081777.

Stromal and immune cells in the tumor microenvironment (TME) have been shown to directly affect high-grade serous ovarian cancer (HGSC) malignant phenotypes, however, how these cells interact to influence HGSC patients' survival remains largely unknown. To investigate the cell-cell...

Cite
Zhu Y, Ferri-Borgogno S, Sheng J, et al. SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor Microenvironment. Cancers (Basel). 2021;13(8)doi: 10.3390/cancers13081777.
Zhu, Y., Ferri-Borgogno, S., Sheng, J., Yeung, T. L., Burks, J. K., Cappello, P., Jazaeri, A. A., Kim, J. H., Han, G. H., Birrer, M. J., Mok, S. C., & Wong, S. T. C. (2021). SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor Microenvironment. Cancers, 13(8), . https://doi.org/10.3390/cancers13081777
Zhu, Ying, et al. "SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor Microenvironment." Cancers vol. 13,8 (2021). doi: https://doi.org/10.3390/cancers13081777
Zhu Y, Ferri-Borgogno S, Sheng J, Yeung TL, Burks JK, Cappello P, Jazaeri AA, Kim JH, Han GH, Birrer MJ, Mok SC, Wong STC. SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor Microenvironment. Cancers (Basel). 2021 Apr 08;13(8). doi: 10.3390/cancers13081777. PMID: 33917869; PMCID: PMC8068305.
Copy Download .nbib Format: NLM
Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial.

Scientific reports

How JA, Jazaeri AA, Soliman PT, Fleming ND, Gong J, Piha-Paul SA, Janku F, Stephen B, Naing A.
PMID: 33574401
Sci Rep. 2021 Feb 11;11(1):3667. doi: 10.1038/s41598-021-83317-7.

Vaginal and vulvar squamous cell carcinoma (SCC) are rare tumors that can be challenging to treat in the recurrent or metastatic setting. We present a case series of patients with vaginal or vulvar SCC who were treated with single-agent...

Cite
How JA, Jazaeri AA, Soliman PT, et al. Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial. Sci Rep. 2021;11(1):3667doi: 10.1038/s41598-021-83317-7.
How, J. A., Jazaeri, A. A., Soliman, P. T., Fleming, N. D., Gong, J., Piha-Paul, S. A., Janku, F., Stephen, B., & Naing, A. (2021). Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial. Scientific reports, 11(1), 3667. https://doi.org/10.1038/s41598-021-83317-7
How, Jeffrey A, et al. "Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial." Scientific reports vol. 11,1 (2021): 3667. doi: https://doi.org/10.1038/s41598-021-83317-7
How JA, Jazaeri AA, Soliman PT, Fleming ND, Gong J, Piha-Paul SA, Janku F, Stephen B, Naing A. Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial. Sci Rep. 2021 Feb 11;11(1):3667. doi: 10.1038/s41598-021-83317-7. PMID: 33574401; PMCID: PMC7878854.
Copy Download .nbib Format: NLM
Years of life lost (YLL) associated with COVID-19 deaths in Khorasan-RAZAVI province, Iran.

Journal of public health (Oxford, England)

Yousefi M, Fazaeli S, Mohammad-Pour S.
PMID: 34927698
J Public Health (Oxf). 2021 Dec 20; doi: 10.1093/pubmed/fdab392. Epub 2021 Dec 20.

BACKGROUND: The number of deaths among people with coronavirus disease 2019 (COVID-19) does not show the true impact of the disease on communities. Therefore, this study aimed to calculate years of life lost (YLL) due to premature death in...

Cite
Yousefi M, Fazaeli S, Mohammad-Pour S. Years of life lost (YLL) associated with COVID-19 deaths in Khorasan-RAZAVI province, Iran. J Public Health (Oxf). 2021;doi: 10.1093/pubmed/fdab392.
Yousefi, M., Fazaeli, S., & Mohammad-Pour, S. (2021). Years of life lost (YLL) associated with COVID-19 deaths in Khorasan-RAZAVI province, Iran. Journal of public health (Oxford, England), . https://doi.org/10.1093/pubmed/fdab392
Yousefi, Mehdi, et al. "Years of life lost (YLL) associated with COVID-19 deaths in Khorasan-RAZAVI province, Iran." Journal of public health (Oxford, England) vol. (2021). doi: https://doi.org/10.1093/pubmed/fdab392
Yousefi M, Fazaeli S, Mohammad-Pour S. Years of life lost (YLL) associated with COVID-19 deaths in Khorasan-RAZAVI province, Iran. J Public Health (Oxf). 2021 Dec 20; doi: 10.1093/pubmed/fdab392. Epub 2021 Dec 20. PMID: 34927698; PMCID: PMC8754705.
Copy Download .nbib Format: NLM
Modification of Homologous Recombination Deficiency Score Threshold and Association with Long-Term Survival in Epithelial Ovarian Cancer.

Cancers

How JA, Jazaeri AA, Fellman B, Daniels MS, Penn S, Solimeno C, Yuan Y, Schmeler K, Lanchbury JS, Timms K, Lu KH, Yates MS.
PMID: 33668244
Cancers (Basel). 2021 Feb 24;13(5). doi: 10.3390/cancers13050946.

New therapies, such as poly-ADP ribose polymerase inhibitors (PARPi), and immunotherapy treatments have generated great interest in enhancing individualized molecular profiling of epithelial ovarian cancer (EOC) to improve management of the disease. In EOC patients, putative biomarkers for homologous...

Cite
How JA, Jazaeri AA, Fellman B, et al. Modification of Homologous Recombination Deficiency Score Threshold and Association with Long-Term Survival in Epithelial Ovarian Cancer. Cancers (Basel). 2021;13(5)doi: 10.3390/cancers13050946.
How, J. A., Jazaeri, A. A., Fellman, B., Daniels, M. S., Penn, S., Solimeno, C., Yuan, Y., Schmeler, K., Lanchbury, J. S., Timms, K., Lu, K. H., & Yates, M. S. (2021). Modification of Homologous Recombination Deficiency Score Threshold and Association with Long-Term Survival in Epithelial Ovarian Cancer. Cancers, 13(5), . https://doi.org/10.3390/cancers13050946
How, Jeffrey A, et al. "Modification of Homologous Recombination Deficiency Score Threshold and Association with Long-Term Survival in Epithelial Ovarian Cancer." Cancers vol. 13,5 (2021). doi: https://doi.org/10.3390/cancers13050946
How JA, Jazaeri AA, Fellman B, Daniels MS, Penn S, Solimeno C, Yuan Y, Schmeler K, Lanchbury JS, Timms K, Lu KH, Yates MS. Modification of Homologous Recombination Deficiency Score Threshold and Association with Long-Term Survival in Epithelial Ovarian Cancer. Cancers (Basel). 2021 Feb 24;13(5). doi: 10.3390/cancers13050946. PMID: 33668244; PMCID: PMC7956737.
Copy Download .nbib Format: NLM
Improvement of thermostability of cholesterol oxidase from streptomyces Sp. SA-COO by random mutagenesis.

Protein expression and purification

Fazaeli A, Fana SE, Golestani A, Aminian M.
PMID: 34863881
Protein Expr Purif. 2022 Mar;191:106028. doi: 10.1016/j.pep.2021.106028. Epub 2021 Dec 01.

To enhance the thermal stability of Streptomyces Sp. SA-COO cholesterol oxidase, random mutagenesis was used. A random mutant library was generated using two types of error-prone PCR (single step and serial dilution) and two mutants (ChOA-M1 and ChOA-M2) with...

Cite
Fazaeli A, Fana SE, Golestani A, et al. Improvement of thermostability of cholesterol oxidase from streptomyces Sp. SA-COO by random mutagenesis. Protein Expr Purif. 2021;191:106028doi: 10.1016/j.pep.2021.106028.
Fazaeli, A., Fana, S. E., Golestani, A., & Aminian, M. (2022). Improvement of thermostability of cholesterol oxidase from streptomyces Sp. SA-COO by random mutagenesis. Protein expression and purification, 191106028. https://doi.org/10.1016/j.pep.2021.106028
Fazaeli, Aliakbar, et al. "Improvement of thermostability of cholesterol oxidase from streptomyces Sp. SA-COO by random mutagenesis." Protein expression and purification vol. 191 (2022): 106028. doi: https://doi.org/10.1016/j.pep.2021.106028
Fazaeli A, Fana SE, Golestani A, Aminian M. Improvement of thermostability of cholesterol oxidase from streptomyces Sp. SA-COO by random mutagenesis. Protein Expr Purif. 2022 Mar;191:106028. doi: 10.1016/j.pep.2021.106028. Epub 2021 Dec 01. PMID: 34863881.
Copy Download .nbib Format: NLM
Showing 109 to 116 of 116 entries